Coastal Bridge Advisors, LLC Intra Cellular Therapies, Inc. Transaction History

Coastal Bridge Advisors, LLC

  • $360 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$7.26 - $38.49 $156,852 - $831,576
-21,605 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$10.65 - $14.29 $183,126 - $245,716
17,195 Added 389.91%
21,605 $280,000
Q2 2019

Aug 07, 2019
SELL
$10.65 - $14.29 $183,126 - $245,716
-17,195 Reduced 79.59%
4,410 $280,000
Q1 2019

May 08, 2019
BUY
$10.9 - $14.09 $235,494 - $304,414
21,605 New
21,605 $263,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email